The ATM adds to an already heavily diluted equity structure with massive warrant and preferred overhang. Monitor the pace of ATM sales and any further Nasdaq non-compliance triggers — the stock is at $1.32, just above the $1.00 minimum bid, and the company has no further cure period if it dips below for 30 consecutive days.
Price Chart
Executive Summary
BrenX Ltd. filed a 424B5 prospectus supplement for an at-the-market (ATM) offering of up to $2,886,058 in ordinary shares through A.G.P./Alliance Global Partners. The filing is a routine capital raise under an existing shelf registration, with proceeds earmarked for general corporate purposes, working capital, R&D, and project development. The offering represents potential dilution of approximately 52.9% of outstanding shares at the assumed price of $1.32 per share, and the company discloses significant risks including Nasdaq delisting vulnerability, substantial existing warrant and preferred share overhang, and a going-concern qualification in its audited financials.
Key Facts
- ATM offering of up to $2,886,058 in ordinary shares via A.G.P.
- Pro forma share count increases from 1,946,972 to 4,133,380 at $1.32/sh, representing ~52.9% dilution
- Last reported sale price on Oct 13, 2026: $1.32 per share
- Company has $4.814M in EIB debt; accumulated deficit of $122.194M as of June 30, 2026
- Audited financials include a going-concern explanatory paragraph
- Three reverse stock splits executed in 2026 (7-for-1, 5-for-1, 6-for-1) to maintain Nasdaq listing
- Outstanding warrants for 1,900,422 shares and preferred shares convertible into 1,328,746 shares with full-ratchet anti-dilution
- Company incurred aggregate losses of ~$16.4M in the two prior fiscal years
Financial Impact
Up to $2.89M gross proceeds; dilution of ~52.9% of outstanding shares at assumed $1.32 price; pro forma cash increases from $10.566M to $13.240M
Risk Factors
- Immediate delisting risk if bid price falls below $1.00 for 30 consecutive days (no further cure period)
- Massive dilution from existing warrants (1.9M shares), preferred conversions (1.33M shares), and full-ratchet anti-dilution provisions
- Going-concern qualification in audited financials; accumulated deficit of $122.2M
- ATM sales at or near current price will further pressure the stock and trigger anti-dilution adjustments on Alpha's securities
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001213900-26-109458 |
| Document: 0001213900-26-109458-index-headers.html | 0001213900-26-109458 |
| Document: 0001213900-26-109458-index.html | 0001213900-26-109458 |
| Document: 0001213900-26-109458.txt | 0001213900-26-109458 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | 6-K | $0.8615 | awaiting T+5 | — | $0.7600 (+11.78%) |
Oct 14, 2026 12d ago | 6-K | $1.05 $0.8564 | ▲ +18.44% | ▲ +17.42% | $0.7600 (+27.62%) |
Oct 14, 2026 12d ago | 424B5 | $1.05 $0.8564 | ▲ +18.44% | ▲ +17.42% | $0.7600 (+27.62%) |
Oct 5, 2026 22d ago | EFFECT | $1.89 $1.38 | ▼ −26.98% | ▼ −27.41% | $0.7600 (−59.79%) |
Sep 15, 2026 5w ago | 6-K | $2.76 $2.33 | ▼ −15.58% | ▼ −17.69% | $0.7600 (−72.46%) |
Sep 10, 2026 6w ago | EFFECT | $2.85 $2.59 | ▲ +9.12% | ▲ +8.62% | $0.7600 (+73.33%) |
Aug 28, 2026 8w ago | 6-K | $3.89 $2.24 | ▲ +42.42% | ▲ +42.53% | $0.7600 (+80.46%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers